Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (opens original article in a new tab)

Fennec Pharmaceuticals announced inducement grants under Nasdaq Listing Rule 5635(c)(4), including stock options for a new employee.

• Fennec Pharmaceuticals granted 15,000 stock options to a new non-executive employee under Nasdaq Rule 5635(c)(4).
• The stock options have an exercise price of $9.06 per share and a ten-year term.
• The options vest over 24 months with one-third vesting after one year.